Beam Therapeutics Inc. (BEAM) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Beam Therapeutics Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -34.27x | -5.42x | -15.85x | -9.47x | -13.81x | -19.61x |
| P/B Ratio | 2.21x | 2.78x | 2.14x | 3.73x | 6.19x | 15.54x |
| P/S Ratio | 19.62x | 32.14x | 5.56x | 44.95x | 98.73x | 158970.84x |
| Profitability | ||||||
| Gross Margin | 84.0% | -478.7% | 100.0% | -411.5% | -347.8% | -429812.5% |
| Operating Margin | -274.6% | -654.3% | -46.7% | -555.6% | -757.0% | -553166.7% |
| Net Margin | -57.2% | -593.1% | -35.1% | -474.5% | -714.9% | -810800.0% |
| EBITDA Margin | -21.4% | -619.7% | -38.9% | -532.4% | -443.8% | -533437.5% |
| Liquidity | ||||||
| Current Ratio | 13.09x | 4.82x | 5.89x | 4.89x | 5.96x | 3.01x |
| Quick Ratio | 13.09x | 4.82x | 5.89x | 4.89x | 5.96x | 3.01x |
| Leverage | ||||||
| Debt/Equity | 0.24x | 0.22x | 0.18x | 0.24x | 0.18x | 0.44x |
YoY = year-over-year change. Source: FMP..